Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05726903 · ClinicalTrials.gov registry record · Phase 4
Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone
A Phase 4 study of Gender Dysphoria, Adolescent, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT05726903 is a Phase 4 study of Gender Dysphoria, Adolescent that has completed, run by University of Colorado, Denver. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05726903, a Phase 4 study of Gender Dysphoria, Adolescent, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Recommendations regarding contraceptive counseling and reproductive health differ amongst transgender and gender diverse (TGD) youth compared to cis-gender youth. Limited existing literature demonstrates the need for contraceptive counseling that moves beyond cis- and heteronormative assumptions that start with pregnancy prevention and address concerns at the intersection of gender identity. The Investigator's qualitative study will focus on creating best practices regarding equitable contraceptive counseling for TGD youth. The Investigator will recruit transgender youth who are assigned female at birth, and currently or interested in using depo medroxyprogesterone (DMPA). Through focus groups and semi-structured interviews, the investigator hopes to guide providers in creating best practices and more equitable contraceptive counseling for TGD youth and measure satisfaction of DMPA in TGD youth.
Conditions Studied
Interventions
- DRUG Depo-subQ Provera Injectable Product
Study Locations (1)
Colorado
- Comprehensive Women's Health Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-12-06 |
| Est. Completion | 2023-11-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05726903
The ClinicalTrials.gov registry entry for NCT05726903 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gender Dysphoria, Adolescent appearing as the primary indexed condition, and to 1 intervention - of which Depo-subQ Provera Injectable Product is the first listed.
NCT05726903 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT05726903 about?
NCT05726903 is a clinical study titled "Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone". Recommendations regarding contraceptive counseling and reproductive health differ amongst transgender and gender diverse (TGD) youth compared to cis-gender youth. Limited existing literature demonstrates the need for contraceptive counseling that moves beyond cis- and heteronormative assumptions tha...
What is the current status of trial NCT05726903?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2022-12-06. Estimated completion is 2023-11-17.
What conditions does trial NCT05726903 study?
This clinical trial studies the following conditions: Gender Dysphoria, Adolescent.
What interventions are being tested in trial NCT05726903?
The interventions under investigation include: Depo-subQ Provera Injectable Product (DRUG).
Who is sponsoring clinical trial NCT05726903?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05726903 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.